A forthcoming article for the special issue of the Journal of Law, Medicine and Ethics (JLME), edited by Marc Rodwin and supported by the Edmond J. Safra Center for Ethics, presents evidence that about 90 percent of all new drugs approved by the FDA over the past 30 years are little or no more effective for patients than existing drugs. All…
Tag: Drug Trials
AE Daily reports “U.K. Scientists Say Hydroxychloroquine May Still Have Promise, No Drug Has Been Politicized Like This”
British scientists have said hydroxychloroquine may still have promise as a preventive treatment for COVID-19 but the drug has become so politicized that studies investigating whether or not it is effective are being hampered. The goal is to investigate whether or not hydroxychloroquine and the related drug chloroquine are effective in preventing or reducing the…
Scientific American reports “Shortcuts in COVID-19 Drug Research Could Do Long-Term Harm, Bioethicists Worry”
Compassionate use of experimental medicine needs to coexist with scientific rigor to help patients, researchers write in the journal Science Does a widespread medical emergency justify speedier, and sometimes less rigorous, ways to test treatments and evaluate results? Doctors and patients urgently need to get their hands on drugs for the COVID-19 pandemic.But bioethicists Jonathan Kimmelman…